PCOS Has Been Renamed PMOS: Why the Name Change Matters for Women’s Health
PCOS has been renamed Polyendocrine Metabolic Ovarian Syndrome, or PMOS. Here’s why the name changed, who drove the global effort, and what it means for patients.
For decades, PCOS sounded like an ovary problem.
For many people living with it, that never matched the reality.
The condition historically known as polycystic ovary syndrome, or PCOS, has now been renamed Polyendocrine Metabolic Ovarian Syndrome, or PMOS.
That might sound like a simple name change. It is not.
The old name focused heavily on “polycystic ovaries” and created the impression that the condition was mainly about cysts, ovaries, or fertility. But PCOS has never been that simple. It can affect hormones, metabolism, menstrual cycles, skin, hair, insulin regulation, fertility, cardiovascular risk, mental health, and long-term wellbeing.
In other words: it was never just about cysts. And many of those “cysts” were not even cysts. They were ovarian follicles. Medicine really said “close enough” and ran with it for nearly a century. Cool cool cool.
What is the new name for PCOS?
PCOS will now be known as PMOS, which stands for:
Polyendocrine Metabolic Ovarian Syndrome
The new name is designed to better reflect what the condition actually involves.
Polyendocrine means multiple hormone systems may be involved.
Metabolic reflects the condition’s connection with insulin resistance, weight regulation, blood glucose, diabetes risk, cardiovascular risk, and broader metabolic health.
Ovarian recognises that the ovaries and ovulation can still be involved, but without making the condition sound like it is only about ovarian cysts.
This matters because names shape how conditions are understood. They influence what patients search for, what doctors look for, what symptoms get connected, and what gets dismissed.
Why was the old name PCOS considered misleading?
The old name, polycystic ovary syndrome, was misleading for several reasons.
First, the “cysts” in PCOS are not true cysts. They are usually small ovarian follicles. Second, not everyone with PCOS has polycystic-looking ovaries on ultrasound. Third, some people have significant hormonal and metabolic symptoms, but their care gets narrowed down to periods, fertility, weight, or whether their ovaries look a certain way on imaging.
That narrow framing has consequences.
When a condition sounds like it is mainly about ovaries, people may not realise it can also affect insulin, metabolism, skin, hair, mood, cardiovascular risk, and long-term health. Clinicians may also miss the broader pattern, especially if someone is not currently trying to conceive.
That is a problem. Because PMOS is not just a fertility condition. It is not just a period problem. It is not just acne. It is not just weight. It is not just “hormones being annoying.” It is a complex endocrine and metabolic condition that deserves to be recognised properly.
Who drove the PCOS name change?
The PCOS to PMOS name change was not decided overnight. It followed more than a decade of international work involving researchers, clinicians, medical societies, and people with lived experience. The Endocrine Society described the change as the result of a global effort to improve diagnosis and care for a condition affecting around 1 in 8 women, or more than 170 million women worldwide.
The process involved the International PCOS Network, global experts, health professionals, and people with lived experience of the condition. The people living with the condition were not just an afterthought. Their experiences helped drive the push for a name that better reflects what PMOS actually feels like and does in real life.
According to Australian reporting, the name change followed 14 years of research and a patient-focused process that included more than 22,000 survey responses.
Why did people push for the name change?
The main driver behind the name change was accuracy.
The old name did not properly describe the condition. It overemphasised cysts and ovaries, while underplaying the broader hormonal, metabolic, psychological, reproductive, and long-term health impacts. People pushed for the name change because the old terminology could contribute to confusion, missed diagnosis, delayed care, and poor understanding.
The new name, PMOS, aims to:
Improve understanding of the condition
Reflect the endocrine and metabolic nature of the syndrome
Reduce the misleading focus on ovarian cysts
Support better diagnosis and management
Encourage clinicians to consider the whole-body impact
Reduce stigma and cultural barriers
Validate what patients have been saying for years
Many people with PCOS have known for a long time that the old name did not fit. They were dealing with fatigue, irregular cycles, acne, excess hair growth, hair thinning, insulin resistance, weight changes, fertility concerns, mood symptoms, and long-term health worries — while the name kept pointing everyone back to “cysts.”
The name PMOS is not perfect. No medical name ever is. But it is more accurate. And in women’s health, accuracy matters.
What symptoms and health issues can PMOS involve?
PMOS can look different from person to person. Not everyone will experience every symptom, and symptoms can change across life stages.
PMOS may involve:
Irregular or absent periods
Irregular ovulation
Higher androgen levels
Acne
Excess facial or body hair
Scalp hair thinning
Weight changes or difficulty with weight regulation
Insulin resistance
Fertility challenges
Metabolic risk
Cardiovascular risk
Anxiety, depression, or reduced quality of life
The key point is that PMOS is a syndrome. It is a pattern of related features, not one single symptom.
That is one reason the old name caused problems. It made the condition sound like something that could be confirmed or dismissed by looking for “cysts.” But PMOS is bigger than an ultrasound finding.
Does the name change affect diagnosis or treatment?
The name change does not mean everyone needs a new diagnosis.
If you have previously been diagnosed with PCOS, that diagnosis does not suddenly disappear. You may see both terms used for a while: PCOS in older records, guidelines, articles, and medical systems; PMOS in newer education, research, and advocacy. The clinical transition will take time. Reporting indicates that the new name is expected to be fully implemented in the 2028 International Guideline update, following a period of education and awareness. The name change also does not mean you should self-diagnose based on social media content. PMOS still requires proper clinical assessment.
However, the new name may help shift care in a better direction. Instead of treating the condition as mainly an ovary or fertility issue, PMOS encourages a broader view. That means looking at the reproductive, endocrine, metabolic, skin, hair, mental health, and long-term health features together.
That is the whole point.
The body is not a filing cabinet. Symptoms do not politely stay in one drawer.
What does this mean if you already have PCOS?
If you already have a PCOS diagnosis, you can start using both terms if that feels useful.
For example, you might say:
“I have PCOS, which is now being renamed PMOS.”
Or:
“I have PCOS/PMOS, and I’d like to make sure my care plan considers the metabolic and endocrine aspects too.”
You do not need to panic. You do not need to throw out every resource that says PCOS. What you can do is use the name change as an opportunity to ask better questions. Because the new name gives patients better language. And better language can help people advocate for more complete care.
Why the PCOS to PMOS name change matters for women’s health
The name change matters because women’s symptoms are often fragmented.
One doctor looks at the periods. Another looks at the acne. Another comments on weight. Another asks about fertility. Another suggests stress. And the person living in the body is left trying to connect the dots alone. PMOS is not a magic fix. It will not instantly undo years of delayed diagnosis, fragmented care, or medical dismissal. But it does give us a more accurate starting point. And starting points matter.
When a condition is named badly, it can be understood badly. When it is understood badly, it can be treated badly. And when it is treated badly, patients pay the price. The shift from PCOS to PMOS recognises something people with the condition have known for years:
This was never just about cysts.
It was always bigger than that.
FAQ: PCOS renamed PMOS
What is PCOS called now?
PCOS has been renamed Polyendocrine Metabolic Ovarian Syndrome, or PMOS.
Why was PCOS renamed PMOS?
PCOS was renamed because the old name overemphasised ovarian “cysts” and did not properly reflect the broader endocrine and metabolic nature of the condition.
Are PCOS and PMOS the same condition?
Yes. PMOS is the new name for the condition previously known as PCOS.
Does everyone with PMOS have ovarian cysts?
No. Not everyone with the condition has polycystic-looking ovaries. The so-called “cysts” are also not true cysts; they are ovarian follicles.
Do I need a new diagnosis if I already have PCOS?
Not necessarily. If you already have a PCOS diagnosis, the name change does not automatically invalidate it. However, you may want to speak with your healthcare provider about whether your current care plan considers the full endocrine and metabolic nature of the condition.
Will doctors still use the term PCOS?
Yes, many clinicians and health systems may continue using PCOS during the transition period. It may take time for medical records, guidelines, education materials, and public awareness to catch up.
Is PMOS only about fertility?
No. PMOS can affect fertility and ovulation, but it can also involve hormones, metabolism, skin, hair, insulin resistance, cardiovascular risk, and mental health.
A note from Totally Fine Co.
This article is for general education only and is not a diagnosis or medical advice. If you have symptoms, concerns, or questions about PCOS, PMOS, or your health, please speak with a qualified healthcare professional.
You know your body. You deserve to be taken seriously. And you deserve care that looks at the whole picture.
References
American Society for Reproductive Medicine. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/
Australian Associated Press. (2026, May 13). New name ends confusion over disorder affecting women. https://aapnews.aap.com.au/news/new-name-ends-confusion-over-disorder-affecting-women
Australian Broadcasting Corporation. (2026, May 12). The name of this health condition was “very inaccurate”. Now it’s changed. ABC News. https://www.abc.net.au/news/health/2026-05-12/polyendocrine-metabolic-ovarian-syndrome-pcos-new-name/106668902
Endocrine Society. (2026, May 12). Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change
Monash University. (2025, May 29). Polycystic Ovary Syndrome: Raising awareness and changing the name led by experts, health professionals and those with lived experience. https://www.monash.edu/news/articles/polycystic-ovary-syndrome-raising-awareness-and-changing-the-name-led-by-experts,-health-professionals-and-those-with-lived-experience
RANZCOG. (2026, May 13). RANZCOG welcomes Polycystic Ovarian Syndrome (PCOS) renaming to Polyendocrine Metabolic Ovarian Syndrome (PMOS). https://ranzcog.edu.au/news/ranzcog-welcomes-polycystic-ovarian-syndrome-pcos-renaming-to-polyendocrine-metabolic-ovarian-syndrome-pmos/
Teede, H. J., et al. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome. The Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext
Women’s Health in Reproductive Life Centre for Research Excellence. (n.d.). Renaming PCOS. https://whirlcre.edu.au/pcos-name-change/
